Organs-on-Chips Market
Organs-on-Chips Market Analysis by Liver, Heart, and Lungs for Drug Discovery and Toxicology Research from 2023 to 2033
Analysis of Organs-on-Chips Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Organs-on-Chips Market Outlook (2023 to 2033)
The global organs-on-chips market size is valued at US$ 103 million in 2023 and is predicted to surge and attain an impressive valuation of US$ 1.45 billion by 2033-end. As per this elaborate Fact.MR research study, worldwide shipments of organs-on-chips are projected to rise at an astronomical 30.3% CAGR over the next ten years.
Organs-on-chips or organoid chips are masses of cells or tissues that emulate the function of an organ or different types of organs. Organs-on-chips are anticipated to find extensive use in the drug development process as they allow researchers to study the exact impact of drugs on organs and get a detailed analysis of effects at the cellular and molecular level, which is expected to drive sales of organs-on-chips through 2033.
Rising concerns regarding the testing of drugs on animals, growing demand for personalized medicine, increasing investments in healthcare research, and supportive government funding are other factors that are expected to positively influence the organs-on-chips market potential across the forecast period. Shortage of organ donors and lack of availability of functional lab-engineered organs are also slated to drive shipments of organs-on-chips over the next five years.
- In March 2023, MIMETAS, a leading company using organ-on-chip technology for disease modelling based in the Netherlands, announced that it had launched its Adult Stem Cell (ASC)-derived tubular organoids in an assay-ready format as part of its OrganoReady® product line.
The advent of 3D bioprinting in the medical technology sector is projected to allow organ-on-chip companies to reduce their manufacturing and deployment costs, which could further boost organ-on-chip demand in the long run. Innovations in biomaterials and advancements in 3D printing technology are also slated to aid organ-on-chip vendors in scaling their business to the next level.
- In April 2023, BIO INX, a Belgian start-up developing inks for a wide scope of applications such as bioprinting and 3D printing, revealed its new resin that could be used to 3D print organs-on-chips. Hydrotech INX N200 is a biocompatible hydrogel resin created for two-photon polymerization (2PP).
Contrastingly, organs-on-chips technology is still in its nascent stage, which is why it requires heavy investments to develop, commercialize, and launch. This also results in expensive end products that are so high in cost that the majority of the general population around the world cannot afford them. The aforementioned aspects act as major restraints for organs-on-chips market revenue generation throughout the forecast period.
Report Attributes | Details |
---|---|
Organs-on-Chips Market Size (2023) |
US$ 103 Million |
Projected Market Value (2033F) |
US$ 1.45 Billion |
Global Market Growth Rate (2023 to 2033) |
30.3% CAGR |
Leading Regional Market |
North America |
Key Market Segment |
Lungs-on-Chips |
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are Start-ups Doing to Bridge the Gap in the Organs-on-Chips Industry?
“Capital Raise – Essential for New Organ-on-Chip Companies Trying to Innovate”
Organs-on-chips is a technology that is still in its nascent and developmental phases, which is why it requires a substantial amount of research and development that incurs high costs for companies developing them. This is why incoming organs-on-chips providers are focusing on raising new funding to finance their R&D efforts and improve their business potential in the future.
- In June 2023, Dynamic42 GmbH, an innovative organ-on-chip specialist based in Germany, announced that it had closed a mid-seven-figure Series A financing round to expand its business on an international level. Lead investor bm-t beteiligungsmanagement thüringen GmbH has played a crucial role in funding this start-up right from 2018.
- In August 2022, Nortis, a company focusing on developing organ-on-chip technology using microfluidics, announced that it had raised US$ 6 million in cash. This was revealed in an SEC filing and the company is focusing on the development of human cells that can mimic the function of organs such as kidney, liver, lungs, heart, etc.
- Emulate Inc., a biotechnology start-up focused on organ-on-a-chip technology, announced that it had raised US$ 82 million in a Series E round in September 2021. The company had plans to utilize this funding to create a blueprint for developing novel organ systems that could be used by drug makers in labs to eliminate the need for animal testing.
- Finnadvance, a Finnish organ-on-chip start-up, announced that it has raised around US$ 1.19 million in a seed funding round in April 2022, which was led by Athensmed and was backed by Voima Ventures and Icebreaker who are the existing investors of the company. Finnadvance was expected to use this funding to broaden its research scope and reach out to new markets such as the United States.
Start-ups can benefit by learning more about aspects such as local supply, pricing trends, product standards, safety regulations, and new developments that have been discussed extensively in this organs-on-chips industry study by skilled analysts at Fact.MR, a market research and competitive intelligence provider.
Country-wise Insights
Where in Asia Will Organ-on-Chip Companies Get Sizeable Returns on Their Investments?
“China and India to Offer Lucrative Moneymaking Opportunities”
Organs-on-chips market revenue share in Asian countries such as India and China is projected to increase at a rapid pace across the forecast period and beyond. This can be ascribed to a rising focus on healthcare innovation and growing investments in medical R&D activities in the aforementioned Asian countries.
Surging incidence of chronic diseases, growing patient pool, and rising mortality rates due to unavailability of organ donors are other influential prospects that could potentially bolster organ-on-chip sales in Japan, China, India along with other Asian countries over the next ten years.
Why Should Organ-on-Chip Manufacturers Invest in the United States?
“High Healthcare Expenditure and Rapid Adoption of Novel Technologies”
The U.S. organs-on-chips market is expected to be a highly lucrative market over the years to come and the growth can be attributed to the increasing geriatric population, high research activity in the healthcare industry, supportive government initiatives, presence of key pharmaceutical and biotechnology companies, and rising acceptance of organs-on-chips.
The country is home to some of the major biotechnology and pharmaceutical companies, and a high focus on R&D in these organizations is expected to favour the overall market potential through 2033. The presence of an advanced healthcare infrastructure that is quick to adopt novel healthcare technologies also makes the United States a highly remunerative space for organ-on-chip companies going forward
Which European Countries are Key Markets for Suppliers of Organs-on-Chips?
“Germany, United Kingdom – Opportune Markets in Europe”
Sizeable amounts of investments have been made in research and development of organ-on-chip technology in European countries such as Germany and the United Kingdom. Germany is home to some of the most prominent start-ups making waves in the organs-on-chips space and this is why the country has become a hotbed for innovations in the marketplace thereby attracting investors.
Increasing focus on healthcare and rising demand for drug discovery and screening are anticipated to be prime drivers for organ-on-chip demand in the United Kingdom. Supportive initiatives by the government to promote R&D in the organs-on-chips space are also opening up new frontiers of opportunities for established as well as new organ-on-chip companies going forward.
- In 2020, a new research center was opened at Queen Mary University of London to facilitate medical research and drug development using organ-on-chip technology. The ‘Queen Mary-Emulate Organs-on-Chips Centre’ was established through a partnership between Emulate Inc., a United States-based company developing organs-on-chips, and Queen Mary University.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Which Type Organs-on-Chip is Exhibiting High Demand?
“Lungs-on-Chips to Account for Substantial Sales Growth”
The global organs-on-chips market, based on organ, is segmented into liver, heart, lungs, and other organs.
The lungs segment is anticipated to lead the overall organs-on-chips market revenue generation capacity owing to lower lung transplantations and increasing investments in the development of lungs-on-chips. The rising use of lab-engineered lungs in the drug screening process owing to the high prevalence of respiratory disorders is also expected to drive growth in this segment over the years to come.
Demand for heart-on-chip is also anticipated to exhibit a lucrative growth outlook owing to the increasing incidence of cardiovascular disorders across the world which is expected to rise as the senescent population increases through 2033.
Competitive Landscape
Leading organ-on-chip manufacturers are focusing on mergers, collaborations, and acquisitions to expand their business scope and bolster their presence in the global competitive landscape.
- In April 2022, Valo Health, a technology company focused on revolutionizing the drug discovery process, announced that it was acquiring TARA Biosystems to bolster its cardiovascular drug discovery business. TARA’s 3D heart tissue modelling platform and its heart tissue chips will be key to Valo’s advancements in cardiovascular drug discovery and development.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments of Organs-on-Chips Industry Research
-
By Organ :
- Liver
- Heart
- Lungs
- Other Organs
-
By Application :
- Drug Discovery
- Toxicology Research
- Other Applications
-
By End User :
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
- Other End Users
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Organs-on-Chips 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2022 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Source Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Organs-on-Chips 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018-2022 and Forecast, 2023-2033 5.1. Historical Market Value (US$ Mn) Analysis, 2018-2022 5.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Organ 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Organ, 2018-2022 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Organ, 2023-2033 6.3.1. Liver 6.3.2. Heart 6.3.3. Lungs 6.3.4. Other Organs 6.4. Market Attractiveness Analysis By Organ 7. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Application 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Application , 2018-2022 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2023-2033 7.3.1. Drug Discovery 7.3.2. Toxicology Research 7.3.3. Other Applications 7.4. Market Attractiveness Analysis By Application 8. Global Market Analysis 2018-2022 and Forecast 2023-2033, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018-2022 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023-2033 8.3.1. Pharmaceutical & Biotechnology Companies 8.3.2. Academic & Research Institutions 8.3.3. Other End Users 8.4. Market Attractiveness Analysis By End User 9. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018-2022 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018-2022 and Forecast 2023-2033 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Organ 10.3.3. By Application 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Organ 10.4.3. By Application 11. Latin America Market Analysis 2018-2022 and Forecast 2023-2033 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Organ 11.3.3. By Application 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Organ 11.4.3. By Application 11.4.4. By End User 12. Europe Market Analysis 2018-2022 and Forecast 2023-2033 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. UK 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Organ 12.3.3. By Application 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Organ 12.4.3. By Application 12.4.4. By End User 13. East Asia Market Analysis 2018-2022 and Forecast 2023-2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Organ 13.3.3. By Application 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Organ 13.4.3. By Application 13.4.4. By End User 14. South Asia & Oceania Market Analysis 2018-2022 and Forecast 2023-2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Organ 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Organ 14.4.3. By Application 14.4.4. By End User 15. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Organ 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Organ 15.4.3. By Application 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. CN Bio Innovations 17.3.1.1. Company Overview 17.3.1.2. Source overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. InSphero 17.3.2.1. Company Overview 17.3.2.2. Source overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. BioIVT 17.3.3.1. Company Overview 17.3.3.2. Source overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Kirkstall 17.3.4.1. Company Overview 17.3.4.2. Source overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. HemoShear Therapeutics LLC 17.3.5.1. Company Overview 17.3.5.2. Source overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Visikol 17.3.6.1. Company Overview 17.3.6.2. Source overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. SynVivo 17.3.7.1. Company Overview 17.3.7.2. Source overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. AxoSim 17.3.8.1. Company Overview 17.3.8.2. Source overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Nortis 17.3.9.1. Company Overview 17.3.9.2. Source overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Emulate Inc. 17.3.10.1. Company Overview 17.3.10.2. Source overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 17.3.11. Tara Biosystems Inc. 17.3.11.1. Company Overview 17.3.11.2. Source overview 17.3.11.3. SWOT Analysis 17.3.11.4. Key Developments 17.3.12. MIMETAS 17.3.12.1. Company Overview 17.3.12.2. Source overview 17.3.12.3. SWOT Analysis 17.3.12.4. Key Developments 17.3.13. Organovo Holdings Inc. 17.3.13.1. Company Overview 17.3.13.2. Source overview 17.3.13.3. SWOT Analysis 17.3.13.4. Key Developments 17.3.14. TissUse GmbH 17.3.14.1. Company Overview 17.3.14.2. Source overview 17.3.14.3. SWOT Analysis 17.3.14.4. Key Developments 17.3.15. Hesperos Inc. 17.3.15.1. Company Overview 17.3.15.2. Source overview 17.3.15.3. SWOT Analysis 17.3.15.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Organ, 2018-2022
Table 02: Global Market Value (US$ Mn) Analysis, by Organ, 2023-2033
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033
Table 04: Global Market Value (US$ Mn) Analysis, by Application, 2018-2022
Table 05: Global Market Value (US$ Mn) Analysis, by Application, 2023-2033
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018-2022
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2023-2033
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018-2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023-2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023-2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018-2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023-2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033
Table 16: North America Market Value (US$ Mn) Analysis, by Organ, 2018-2022
Table 17: North America Market Value (US$ Mn) Analysis, by Organ, 2023-2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033
Table 19: North America Market Value (US$ Mn) Analysis, by Application, 2018-2022
Table 20: North America Market Value (US$ Mn) Analysis, by Application, 2023-2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018-2022
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023-2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018-2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023-2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Organ, 2018-2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Organ, 2023-2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Application, 2018-2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Application, 2023-2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018-2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023-2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018-2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023-2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Organ, 2018-2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Organ, 2023-2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Application, 2018-2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Application, 2023-2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018-2022
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023-2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018-2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023-2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Organ, 2018-2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Organ, 2023-2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Application, 2018-2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Application, 2023-2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018-2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023-2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018-2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023-2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Organ, 2018-2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Organ, 2023-2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018-2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2023-2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018-2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023-2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018-2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023-2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Organ, 2018-2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Organ, 2023-2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Application, 2018-2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Application, 2023-2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018-2022
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023-2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018-2022
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023-2033
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018-2033
Figure 04: Global Market Incremental $ Opportunity, 2023-2033
Figure 05: Global Market Share and BPS Analysis by Organ, 2023 & 2033
Figure 06: Global Market Y-o-Y Growth Projections by Organ, 2023-2033
Figure 07: Global Market Attractiveness Analysis by Organ, 2023-2033
Figure 08: Global Market Share and BPS Analysis by Application, 2023 & 2033
Figure 09: Global Market Y-o-Y Growth Projections by Application, 2023-2033
Figure 10: Global Market Attractiveness Analysis by Application, 2023-2033
Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023-2033
Figure 13: Global Market Attractiveness Analysis by End User, 2023-2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023-2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023-2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018-2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023-2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2023-2033
Figure 20: North America Market Incremental $ Opportunity, 2023-2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023-2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023-2033
Figure 24: North America Market Share and BPS Analysis by Organ, 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Organ, 2023-2033
Figure 26: North America Market Attractiveness Analysis by Organ, 2023-2033
Figure 27: North America Market Share and BPS Analysis by Application, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Application, 2023-2033
Figure 29: North America Market Attractiveness Analysis by Application, 2023-2033
Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023-2033
Figure 32: North America Market Attractiveness Analysis by End User, 2023-2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018-2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023-2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018-2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023-2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023-2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023-2033
Figure 40: Latin America Market Share and BPS Analysis by Organ, 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Organ, 2023-2033
Figure 42: Latin America Market Attractiveness Analysis by Organ, 2023-2033
Figure 43: Latin America Market Share and BPS Analysis by Application, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Application, 2023-2033
Figure 45: Latin America Market Attractiveness Analysis by Application, 2023-2033
Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023-2033
Figure 48: Latin America Market Attractiveness Analysis by End User, 2023-2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018-2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023-2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018-2033
Figure 52: Europe Market Incremental $ Opportunity, 2023-2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023-2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023-2033
Figure 56: Europe Market Share and BPS Analysis by Organ, 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Organ, 2023-2033
Figure 58: Europe Market Attractiveness Analysis by Organ, 2023-2033
Figure 59: Europe Market Share and BPS Analysis by Application, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Application, 2023-2033
Figure 61: Europe Market Attractiveness Analysis by Application, 2023-2033
Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023-2033
Figure 64: Europe Market Attractiveness Analysis by End User, 2023-2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018-2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023-2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018-2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023-2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023-2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023-2033
Figure 72: East Asia Market Share and BPS Analysis by Organ, 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Organ, 2023-2033
Figure 74: East Asia Market Attractiveness Analysis by Organ, 2023-2033
Figure 75: East Asia Market Share and BPS Analysis by Application, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Application, 2023-2033
Figure 77: East Asia Market Attractiveness Analysis by Application, 2023-2033
Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023-2033
Figure 80: East Asia Market Attractiveness Analysis by End User, 2023-2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018-2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023-2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018-2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023-2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023-2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023-2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Organ, 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Organ, 2023-2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Organ, 2023-2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Application, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2023-2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Application, 2023-2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023-2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023-2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018-2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023-2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018-2033
Figure 100: MEA Market Incremental $ Opportunity, 2023-2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023-2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023-2033
Figure 104: MEA Market Share and BPS Analysis by Organ, 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Organ, 2023-2033
Figure 106: MEA Market Attractiveness Analysis by Organ, 2023-2033
Figure 107: MEA Market Share and BPS Analysis by Application, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Application, 2023-2033
Figure 109: MEA Market Attractiveness Analysis by Application, 2023-2033
Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023-2033
Figure 112: MEA Market Attractiveness Analysis by End User, 2023-2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the organs-on-chips market in 2023?
The global organs-on-chips market accounts for a valuation of US$ 103 million in 2023.
What is the projected organs-on-chips market size for 2033?
Organ-on-chip sales are forecasted to reach US$ 1.45 billion by 2033-end.
At what CAGR is the global market projected to expand?
Worldwide sales of organs-on-chips are predicted to skyrocket at 30.3% CAGR over the next ten years.
Which organs-on-chips will witness higher demand through 2033?
Lungs-on-chips are estimated to account for high sales across the forecast period.
Who are the major organ-on-chip manufacturing companies in the industry?
SynVivo, Tara Biosystems Inc., MIMETAS, HemoShear Therapeutics LLC, Organovo Holdings Inc., AxoSim, and Nortis are some of the leading companies in the market.